Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
| AHSCX Fund | USD 13.42 0.03 0.22% |
Slightly above 55% of Alger Health's investor base is interested to short. The analysis of overall sentiment of trading Alger Health Sciences mutual fund suggests that many investors are impartial at this time. Alger Health's investing sentiment can be driven by a variety of factors including economic data, Alger Health's earnings reports, geopolitical events, and overall market trends.
Alger |
Aldeyra Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has accepted for review the resub
Read at businesswire.com
 |
Alger Health Fundamental Analysis
We analyze Alger Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alger Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alger Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Alger Health is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Alger Health Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alger Health mutual fund to make a market-neutral strategy. Peer analysis of Alger Health could also be used in its relative valuation, which is a method of valuing Alger Health by comparing valuation metrics with similar companies.
Peers
Alger Health Related Equities
| BSGSX | Baird Small/mid | 1.91 | ||||
| APDSX | Artisan Small | 1.81 | ||||
| MCSCX | M3sixty Capital | 1.56 | ||||
| AATSX | Ancora/thelen Small-mid | 1.54 | ||||
| GLVIX | Glg Intl | 0.67 |
Other Information on Investing in Alger Mutual Fund
Alger Health financial ratios help investors to determine whether Alger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alger with respect to the benefits of owning Alger Health security.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |